AstraZeneca is resuming late-stage development ... enrolment at some clinical study sites and the EAGLE trial is expected to resume shortly, without changes to either protocol.

AstraZeneca, which paused the late-stage ... across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this ...

Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after being paused due to a reported side effect in a patient in the UK. On Tuesday, AstraZeneca said ...

Phase III clinical trials of Russia’s Sputnik V vaccine against COVID-19 will be conducted in the Brazilian states of Bahia and Parana, which has plans to produce the vaccine for Brazil and ...

London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that ...

Clinical trials of AstraZeneca and Oxford University's COVID-19 vaccine have resumed in Japan, almost one month after the company halted large-scale global tests after a participant fell ill.

A Phase 3 trial found AstraZeneca's experimental lung cancer drug did not significantly improve patients' overall survival rates.

Two major coronavirus vaccines will resume late-stage trials in the US The Food and Drug Administration has allowed a COVID-19 a vaccine trial commissioned by AstraZeneca and the University of ...

AstraZeneca’s Imfinzi recently became the first PD-1/L1 inhibitor to deliver a patient survival win in muscle-invasive ...

AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has failed to improve overall survival (OS) in ...

--(BUSINESS WIRE)--Results from the DESTINY-Breast12 Phase IIIb/IV trial showed that ENHERTU ® (fam-trastuzumab ... discovered by Daiichi Sankyo and being jointly developed and commercialized by ...

UK stocks are holding firm, with the FTSE 100 up 0.3% and the FTSE 250 by 0.9%. US stocks are now open and aren’t moving much ...